Kobayashi Pharmaceutical Co., Ltd.
KBYPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $51 | $72 | $96 | $95 |
| Short-Term Investments | $15 | $8 | $8 | $14 |
| Receivables | $49 | $53 | $48 | $55 |
| Inventory | $24 | $22 | $18 | $15 |
| Other Curr. Assets | $5 | $3 | $3 | $3 |
| Total Curr. Assets | $144 | $158 | $173 | $182 |
| Property Plant & Equip (Net) | $67 | $48 | $35 | $23 |
| Goodwill | $9 | $10 | $7 | $7 |
| Intangibles | $11 | $12 | $6 | $5 |
| Long-Term Investments | $10 | $24 | $20 | $15 |
| Tax Assets | $3 | $3 | $2 | $1 |
| Other NC Assets | $20 | $13 | $13 | $19 |
| Total NC Assets | $121 | $109 | $83 | $71 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $265 | $267 | $256 | $253 |
| Liabilities | – | – | – | – |
| Payables | $8 | $17 | $18 | $17 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $2 | $5 | $5 | $4 |
| Deferred Revenue | $0 | $33 | $28 | $28 |
| Other Curr. Liab. | $36 | $1 | $1 | $0 |
| Total Curr. Liab. | $46 | $56 | $52 | $51 |
| LT Debt | $1 | $1 | $1 | $0 |
| Deferred Rev, NC | $0 | $1 | $2 | $2 |
| Deferred Tax Liab, NC | $2 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $5 | $4 | $4 |
| Total NC Liab. | $5 | $7 | $6 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $52 | $63 | $58 | $57 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | $208 | $206 | $194 | $201 |
| AOCI | $26 | $20 | $14 | $11 |
| Other Equity | -$24 | -$24 | -$14 | -$20 |
| Total Equity | $213 | $205 | $198 | $196 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $265 | $267 | $256 | $253 |
| Net Debt | -$50 | -$71 | -$95 | -$94 |